甲状腺激素抵抗β型中的血脂异常、胰岛素抵抗、异位脂质沉积与血管功能
本研究在基因确诊的成人RTHβ患者(n=27-77)中评估动脉粥样硬化风险相关指标,并与健康对照(最多n=100)及甲状腺毒症患者(n=40)比较。结果显示RTHβ患者存在混合型血脂异常、肝内及肌细胞内脂质沉积和胰岛素抵抗,但血管壁厚度与僵硬度未改变、内皮功能增强,整体心血管代谢风险仍待明确。
要点
- RTHβ患者LDL-C与TG升高、HDL-C降低,呈混合型血脂异常。
- RTHβ患者肝内脂质、肌细胞内脂质、HOMA-IR及NEFA显著高于对照。
- RTHβ患者cIMT、PWV、AIx未改变,血流介导舒张反而增加。
核心结论
- RTHβ患者存在混合型血脂异常伴肝内及肌细胞内脂质沉积,提示应监测这些代谢异常。
- 这些代谢异常与增强的内皮功能及未改变的血管壁厚度和顺应性如何共同决定整体心血管代谢风险尚待明确。
研究设计与样本
- 在未筛选、基因确诊的成人RTHβ患者队列(n=27-77)中测量代谢与血管指标。
- 与健康对照(最多n=100)及甲状腺毒症患者(n=40)进行比较。
主要发现
- RTHβ患者LDL-C(P=0.008)和TG(P=0.002)高于对照,HDL-C低于对照(P=0.015×10-2)。
- RTHβ患者LDL-C高于高甲状腺素血症程度相当的甲状腺毒症患者。
- PCSK9(P=0.002)和载脂蛋白B(P=0.0009)在甲状腺毒症患者中降低,但在RTHβ患者或对照中未降低。
- RTHβ患者肝内脂质(P=0.02×10-4)、IMCL(P=0.002)、HOMA-IR(P=0.01×10-2)和NEFA(P=0.04×10-6)显著高于对照。
- RTHβ患者血流介导舒张增加(P=0.04),但cIMT(P=0.71)、PWV(P=0.81)和AIx(P=0.95)未改变。
关键数值与推荐
- RTHβ患者LDL-C P=0.008、TG P=0.002、HDL-C P=0.015×10-2,均与对照比较。
- RTHβ患者肝内脂质P=0.02×10-4、IMCL P=0.002、HOMA-IR P=0.01×10-2、NEFA P=0.04×10-6,均与对照比较。
- RTHβ患者血流介导舒张P=0.04、cIMT P=0.71、PWV P=0.81、AIx P=0.95。
- PCSK9 P=0.002、载脂蛋白B P=0.0009,为甲状腺毒症患者与其余组比较。
临床怎么用
- 对RTHβ患者应监测血脂、胰岛素抵抗及异位脂质沉积等代谢异常。
- 评估心血管风险时需结合代谢异常与血管功能指标,不能仅凭血管壁厚度或僵硬度判断。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In resistance to thyroid hormone due to mutations in thyroid hormone receptor β, peripheral tissues are variably refractory to the action of circulating thyroid hormones. We evaluated parameters contributing to atherosclerotic risk in this disorder. METHODS: We measured low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), nonesterified fatty acids (NEFA), intrahepatic lipid (IHL) and intramyocellular lipid (IMCL), Homeostasis-model assessment of insulin resistance (HOMA-IR), augmentation index (AIx) and pulse wave velocity (PWV), flow-mediated dilatation, and carotid intima-media thickness (cIMT) in an unselected, genetically confirmed cohort of adult RTHβ patients (n = 27-77) and compared these with measurements in healthy subjects (up to n = 100) and thyrotoxic patients (n = 40). RESULTS: Resistance to thyroid hormone beta (RTHβ) patients exhibited higher LDL-C (P = 0.008) and TG (P = 0.002) and lower HDL-C concentrations (P = 0.015 × 10-2) than control subjects, with LDL-C being higher than in thyrotoxic patients with comparable hyperthyroxinemia. Proprotein convertase subtilisin/kexin 9 (P = 0.002) and apolipoprotein B (P = 0.0009) levels were reduced in thyrotoxic patients but not lower in RTHβ patients or control subjects. Intrahepatic lipid (P = 0.02 × 10-4), IMCL (P = 0.002), HOMA-IR (P = 0.01 × 10-2), and NEFA (P = 0.04 × 10-6) were significantly higher in RTHβ patients than control subjects. Flow-mediated dilatation was increased (P = 0.04) but cIMT (P = 0.71), PWV P = 0.81), and AIx (P = 0.95) were unaltered in RTHβ patients. CONCLUSIONS: We have documented mixed dyslipidemia with hepatic and IMCL accumulation in RTHβ, suggesting that surveillance for these metabolic abnormalities is warranted. How they combine with enhanced endothelial function and unaltered vessel wall thickness and compliance to determine overall cardiometabolic risk in this disorder remains to be defined.
引用
- Moran C, McEniery CM, Schoenmakers N, et al. Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β. J Clin Endocrinol Metab. 2021. PMID: 33524107. doi:10.1210/clinem/dgab002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。